img

Global Calcitonin Gene Related Peptide Type 1 Receptor Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Calcitonin Gene Related Peptide Type 1 Receptor Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Calcitonin Gene Related Peptide Type 1 Receptor report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Calcitonin Gene Related Peptide Type 1 Receptor market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Cardiovascular and Metabolic Disorders are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Calcitonin Gene Related Peptide Type 1 Receptor industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Calcitonin Gene Related Peptide Type 1 Receptor key manufacturers include Allergan Plc, Amgen Inc, Biohaven Pharmaceutical Holding Company Ltd, Eli Lilly and Company, Fortress Biotech Inc, Merck & Co Inc, Teva Pharmaceutical Industries Ltd and Vertex Pharmaceuticals Inc, etc. Allergan Plc, Amgen Inc, Biohaven Pharmaceutical Holding Company Ltd are top 3 players and held % sales share in total in 2022.
Calcitonin Gene Related Peptide Type 1 Receptor can be divided into AFAP-3, AGN-241689, CGRP and Erenumab, etc. AFAP-3 is the mainstream product in the market, accounting for % sales share globally in 2022.
Calcitonin Gene Related Peptide Type 1 Receptor is widely used in various fields, such as Cardiovascular, Metabolic Disorders, Dental Pain and Others, etc. Cardiovascular provides greatest supports to the Calcitonin Gene Related Peptide Type 1 Receptor industry development. In 2022, global % sales of Calcitonin Gene Related Peptide Type 1 Receptor went into Cardiovascular filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Calcitonin Gene Related Peptide Type 1 Receptor market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Allergan Plc
Amgen Inc
Biohaven Pharmaceutical Holding Company Ltd
Eli Lilly and Company
Fortress Biotech Inc
Merck & Co Inc
Teva Pharmaceutical Industries Ltd
Vertex Pharmaceuticals Inc
Segment by Type
AFAP-3
AGN-241689
CGRP
Erenumab
Others

Segment by Application


Cardiovascular
Metabolic Disorders
Dental Pain
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Calcitonin Gene Related Peptide Type 1 Receptor market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Calcitonin Gene Related Peptide Type 1 Receptor, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Calcitonin Gene Related Peptide Type 1 Receptor industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Calcitonin Gene Related Peptide Type 1 Receptor in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Calcitonin Gene Related Peptide Type 1 Receptor introduction, etc. Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Calcitonin Gene Related Peptide Type 1 Receptor market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Calcitonin Gene Related Peptide Type 1 Receptor Market Overview
1.1 Calcitonin Gene Related Peptide Type 1 Receptor Product Overview
1.2 Calcitonin Gene Related Peptide Type 1 Receptor Market Segment by Type
1.2.1 AFAP-3
1.2.2 AGN-241689
1.2.3 CGRP
1.2.4 Erenumab
1.2.5 Others
1.3 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size by Type
1.3.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size Overview by Type (2018-2034)
1.3.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Historic Market Size Review by Type (2018-2024)
1.3.3 Global Calcitonin Gene Related Peptide Type 1 Receptor Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Calcitonin Gene Related Peptide Type 1 Receptor Sales Breakdown by Type (2018-2024)
1.4.2 Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales Breakdown by Type (2018-2024)
2 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Competition by Company
2.1 Global Top Players by Calcitonin Gene Related Peptide Type 1 Receptor Sales (2018-2024)
2.2 Global Top Players by Calcitonin Gene Related Peptide Type 1 Receptor Revenue (2018-2024)
2.3 Global Top Players by Calcitonin Gene Related Peptide Type 1 Receptor Price (2018-2024)
2.4 Global Top Manufacturers Calcitonin Gene Related Peptide Type 1 Receptor Manufacturing Base Distribution, Sales Area, Product Type
2.5 Calcitonin Gene Related Peptide Type 1 Receptor Market Competitive Situation and Trends
2.5.1 Calcitonin Gene Related Peptide Type 1 Receptor Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Calcitonin Gene Related Peptide Type 1 Receptor Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Calcitonin Gene Related Peptide Type 1 Receptor as of 2022)
2.7 Date of Key Manufacturers Enter into Calcitonin Gene Related Peptide Type 1 Receptor Market
2.8 Key Manufacturers Calcitonin Gene Related Peptide Type 1 Receptor Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Calcitonin Gene Related Peptide Type 1 Receptor Status and Outlook by Region
3.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Historic Market Size by Region
3.2.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales in Volume by Region (2018-2024)
3.2.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales in Value by Region (2018-2024)
3.2.3 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Calcitonin Gene Related Peptide Type 1 Receptor Forecasted Market Size by Region
3.3.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales in Volume by Region (2024-2034)
3.3.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales in Value by Region (2024-2034)
3.3.3 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Calcitonin Gene Related Peptide Type 1 Receptor by Application
4.1 Calcitonin Gene Related Peptide Type 1 Receptor Market Segment by Application
4.1.1 Cardiovascular
4.1.2 Metabolic Disorders
4.1.3 Dental Pain
4.1.4 Others
4.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size by Application
4.2.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size Overview by Application (2018-2034)
4.2.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Historic Market Size Review by Application (2018-2024)
4.2.3 Global Calcitonin Gene Related Peptide Type 1 Receptor Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Calcitonin Gene Related Peptide Type 1 Receptor Sales Breakdown by Application (2018-2024)
4.3.2 Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales Breakdown by Application (2018-2024)
5 North America Calcitonin Gene Related Peptide Type 1 Receptor by Country
5.1 North America Calcitonin Gene Related Peptide Type 1 Receptor Historic Market Size by Country
5.1.1 North America Calcitonin Gene Related Peptide Type 1 Receptor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Calcitonin Gene Related Peptide Type 1 Receptor Sales in Volume by Country (2018-2024)
5.1.3 North America Calcitonin Gene Related Peptide Type 1 Receptor Sales in Value by Country (2018-2024)
5.2 North America Calcitonin Gene Related Peptide Type 1 Receptor Forecasted Market Size by Country
5.2.1 North America Calcitonin Gene Related Peptide Type 1 Receptor Sales in Volume by Country (2024-2034)
5.2.2 North America Calcitonin Gene Related Peptide Type 1 Receptor Sales in Value by Country (2024-2034)
6 Europe Calcitonin Gene Related Peptide Type 1 Receptor by Country
6.1 Europe Calcitonin Gene Related Peptide Type 1 Receptor Historic Market Size by Country
6.1.1 Europe Calcitonin Gene Related Peptide Type 1 Receptor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales in Volume by Country (2018-2024)
6.1.3 Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales in Value by Country (2018-2024)
6.2 Europe Calcitonin Gene Related Peptide Type 1 Receptor Forecasted Market Size by Country
6.2.1 Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales in Volume by Country (2024-2034)
6.2.2 Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales in Value by Country (2024-2034)
7 Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor by Region
7.1 Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Historic Market Size by Region
7.1.1 Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Forecasted Market Size by Region
7.2.1 Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales in Value by Region (2024-2034)
8 Latin America Calcitonin Gene Related Peptide Type 1 Receptor by Country
8.1 Latin America Calcitonin Gene Related Peptide Type 1 Receptor Historic Market Size by Country
8.1.1 Latin America Calcitonin Gene Related Peptide Type 1 Receptor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales in Volume by Country (2018-2024)
8.1.3 Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales in Value by Country (2018-2024)
8.2 Latin America Calcitonin Gene Related Peptide Type 1 Receptor Forecasted Market Size by Country
8.2.1 Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales in Volume by Country (2024-2034)
8.2.2 Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales in Value by Country (2024-2034)
9 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor by Country
9.1 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Historic Market Size by Country
9.1.1 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Forecasted Market Size by Country
9.2.1 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Allergan Plc
10.1.1 Allergan Plc Company Information
10.1.2 Allergan Plc Introduction and Business Overview
10.1.3 Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Products Offered
10.1.5 Allergan Plc Recent Development
10.2 Amgen Inc
10.2.1 Amgen Inc Company Information
10.2.2 Amgen Inc Introduction and Business Overview
10.2.3 Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Products Offered
10.2.5 Amgen Inc Recent Development
10.3 Biohaven Pharmaceutical Holding Company Ltd
10.3.1 Biohaven Pharmaceutical Holding Company Ltd Company Information
10.3.2 Biohaven Pharmaceutical Holding Company Ltd Introduction and Business Overview
10.3.3 Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Products Offered
10.3.5 Biohaven Pharmaceutical Holding Company Ltd Recent Development
10.4 Eli Lilly and Company
10.4.1 Eli Lilly and Company Company Information
10.4.2 Eli Lilly and Company Introduction and Business Overview
10.4.3 Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Products Offered
10.4.5 Eli Lilly and Company Recent Development
10.5 Fortress Biotech Inc
10.5.1 Fortress Biotech Inc Company Information
10.5.2 Fortress Biotech Inc Introduction and Business Overview
10.5.3 Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Products Offered
10.5.5 Fortress Biotech Inc Recent Development
10.6 Merck & Co Inc
10.6.1 Merck & Co Inc Company Information
10.6.2 Merck & Co Inc Introduction and Business Overview
10.6.3 Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Products Offered
10.6.5 Merck & Co Inc Recent Development
10.7 Teva Pharmaceutical Industries Ltd
10.7.1 Teva Pharmaceutical Industries Ltd Company Information
10.7.2 Teva Pharmaceutical Industries Ltd Introduction and Business Overview
10.7.3 Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Products Offered
10.7.5 Teva Pharmaceutical Industries Ltd Recent Development
10.8 Vertex Pharmaceuticals Inc
10.8.1 Vertex Pharmaceuticals Inc Company Information
10.8.2 Vertex Pharmaceuticals Inc Introduction and Business Overview
10.8.3 Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Products Offered
10.8.5 Vertex Pharmaceuticals Inc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Calcitonin Gene Related Peptide Type 1 Receptor Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Calcitonin Gene Related Peptide Type 1 Receptor Industrial Chain Analysis
11.4 Calcitonin Gene Related Peptide Type 1 Receptor Market Dynamics
11.4.1 Calcitonin Gene Related Peptide Type 1 Receptor Industry Trends
11.4.2 Calcitonin Gene Related Peptide Type 1 Receptor Market Drivers
11.4.3 Calcitonin Gene Related Peptide Type 1 Receptor Market Challenges
11.4.4 Calcitonin Gene Related Peptide Type 1 Receptor Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Calcitonin Gene Related Peptide Type 1 Receptor Distributors
12.3 Calcitonin Gene Related Peptide Type 1 Receptor Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of AFAP-3
Table 2. Major Company of AGN-241689
Table 3. Major Company of CGRP
Table 4. Major Company of Erenumab
Table 5. Major Company of Others
Table 6. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2018-2024) & (K Pcs)
Table 8. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2018-2024) & (US& Million)
Table 10. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Share in Value by Type (2018-2024)
Table 11. Global Calcitonin Gene Related Peptide Type 1 Receptor Price by Type (2018-2024) & (USD/Pcs)
Table 12. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2024-2034) & (K Pcs)
Table 13. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Value by Type (2024-2034)
Table 16. Global Calcitonin Gene Related Peptide Type 1 Receptor Price by Type (2024-2034) & (USD/Pcs)
Table 17. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2018-2024) & (K Pcs)
Table 18. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs) by Type (2018-2024)
Table 20. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs) by Type (2018-2024)
Table 22. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs) by Type (2018-2024)
Table 24. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs) by Type (2018-2024)
Table 26. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Company (2018-2024) & (K Pcs)
Table 28. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Share by Company (2018-2024)
Table 29. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Share by Company (2018-2024)
Table 31. Global Market Calcitonin Gene Related Peptide Type 1 Receptor Price by Company (2018-2024) & (USD/Pcs)
Table 32. Global Calcitonin Gene Related Peptide Type 1 Receptor Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Calcitonin Gene Related Peptide Type 1 Receptor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Calcitonin Gene Related Peptide Type 1 Receptor as of 2022)
Table 35. Date of Key Manufacturers Enter into Calcitonin Gene Related Peptide Type 1 Receptor Market
Table 36. Key Manufacturers Calcitonin Gene Related Peptide Type 1 Receptor Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Region (2018-2024) & (K Pcs)
Table 40. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Value by Region (2018-2024)
Table 43. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 44. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Region (2024-2034) & (K Pcs)
Table 45. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Value by Region (2024-2034)
Table 48. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 49. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2018-2024) & (K Pcs)
Table 51. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Value by Application (2018-2024)
Table 54. Global Calcitonin Gene Related Peptide Type 1 Receptor Price by Application (2018-2024) & (USD/Pcs)
Table 55. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2024-2034) & (K Pcs)
Table 56. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Value by Application (2024-2034)
Table 59. Global Calcitonin Gene Related Peptide Type 1 Receptor Price by Application (2024-2034) & (USD/Pcs)
Table 60. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2018-2024) (K Pcs)
Table 61. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2018-2024) (K Pcs)
Table 63. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2018-2024) (K Pcs)
Table 65. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2018-2024) (K Pcs)
Table 67. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2018-2024) (K Pcs)
Table 69. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2018-2024) & (K Pcs)
Table 71. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Value by Country (2018-2024)
Table 74. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2024-2034) & (K Pcs)
Table 75. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2018-2024) & (K Pcs)
Table 79. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2024-2034) & (K Pcs)
Table 83. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales by Region (2018-2024) & (K Pcs)
Table 87. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales by Region (2024-2034) & (K Pcs)
Table 91. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2018-2024) & (K Pcs)
Table 95. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2024-2034) & (K Pcs)
Table 99. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2018-2024) & (K Pcs)
Table 103. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2024-2034) & (K Pcs)
Table 107. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Value by Country (2024-2034)
Table 110. Allergan Plc Company Information
Table 111. Allergan Plc Introduction and Business Overview
Table 112. Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Product
Table 114. Allergan Plc Recent Development
Table 115. Amgen Inc Company Information
Table 116. Amgen Inc Introduction and Business Overview
Table 117. Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Product
Table 119. Amgen Inc Recent Development
Table 120. Biohaven Pharmaceutical Holding Company Ltd Company Information
Table 121. Biohaven Pharmaceutical Holding Company Ltd Introduction and Business Overview
Table 122. Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Product
Table 124. Biohaven Pharmaceutical Holding Company Ltd Recent Development
Table 125. Eli Lilly and Company Company Information
Table 126. Eli Lilly and Company Introduction and Business Overview
Table 127. Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Product
Table 129. Eli Lilly and Company Recent Development
Table 130. Fortress Biotech Inc Company Information
Table 131. Fortress Biotech Inc Introduction and Business Overview
Table 132. Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Product
Table 134. Fortress Biotech Inc Recent Development
Table 135. Merck & Co Inc Company Information
Table 136. Merck & Co Inc Introduction and Business Overview
Table 137. Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Product
Table 139. Merck & Co Inc Recent Development
Table 140. Teva Pharmaceutical Industries Ltd Company Information
Table 141. Teva Pharmaceutical Industries Ltd Introduction and Business Overview
Table 142. Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Product
Table 144. Teva Pharmaceutical Industries Ltd Recent Development
Table 145. Vertex Pharmaceuticals Inc Company Information
Table 146. Vertex Pharmaceuticals Inc Introduction and Business Overview
Table 147. Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 148. Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Product
Table 149. Vertex Pharmaceuticals Inc Recent Development
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Calcitonin Gene Related Peptide Type 1 Receptor Market Trends
Table 153. Calcitonin Gene Related Peptide Type 1 Receptor Market Drivers
Table 154. Calcitonin Gene Related Peptide Type 1 Receptor Market Challenges
Table 155. Calcitonin Gene Related Peptide Type 1 Receptor Market Restraints
Table 156. Calcitonin Gene Related Peptide Type 1 Receptor Distributors List
Table 157. Calcitonin Gene Related Peptide Type 1 Receptor Downstream Customers
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Calcitonin Gene Related Peptide Type 1 Receptor Product Picture
Figure 2. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of AFAP-3
Figure 6. Global AFAP-3 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of AGN-241689
Figure 8. Global AGN-241689 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of CGRP
Figure 10. Global CGRP Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Erenumab
Figure 12. Global Erenumab Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Type in 2022 & 2034
Figure 17. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Volume by Type in 2022
Figure 18. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Value by Type in 2022
Figure 19. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Volume by Type in 2022
Figure 20. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Value by Type in 2022
Figure 23. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Calcitonin Gene Related Peptide Type 1 Receptor Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Calcitonin Gene Related Peptide Type 1 Receptor Revenue in 2022
Figure 29. Calcitonin Gene Related Peptide Type 1 Receptor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Cardiovascular
Figure 31. Global Cardiovascular Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Metabolic Disorders
Figure 33. Global Metabolic Disorders Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Dental Pain
Figure 35. Global Dental Pain Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2018-2034) & (US$ Million)
Figure 39. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Application in 2022 & 2034
Figure 40. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Volume by Application in 2022
Figure 41. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Value by Application in 2022
Figure 42. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Volume by Application in 2022
Figure 43. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Value by Application in 2022
Figure 46. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Calcitonin Gene Related Peptide Type 1 Receptor Manufacturing Cost Structure
Figure 51. Calcitonin Gene Related Peptide Type 1 Receptor Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries